溢多利(300381) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was ¥513,356,547.37, a decrease of 6.16% year-on-year[7] - Net profit attributable to shareholders of the listed company was ¥53,508,543.51, representing a growth of 21.23% compared to the same period last year[7] - The net profit after deducting non-recurring gains and losses was ¥48,392,200.16, up 16.78% year-on-year[7] - Basic earnings per share increased by 7.20% to ¥0.1146[7] - The company's operating profit for Q3 2020 was approximately ¥78.70 million, an increase of 21.3% compared to ¥64.86 million in the same period last year[42] - Net profit for Q3 2020 reached ¥69.06 million, up 18.3% from ¥58.39 million in Q3 2019[42] - The total comprehensive income for Q3 2020 was ¥69.06 million, compared to ¥58.39 million in the same quarter last year, marking a growth of 18.3%[43] - The total profit for the third quarter was CNY 173.13 million, an increase of 41.3% compared to CNY 122.49 million in the same period last year[49] Assets and Liabilities - Total assets at the end of the reporting period reached ¥4,591,859,517.46, an increase of 1.63% compared to the end of the previous year[7] - The company's total liabilities decreased to CNY 1,472,348,019.32 from CNY 1,789,323,009.37, indicating a reduction of approximately 17.7%[35] - Total assets as of September 30, 2020, amounted to CNY 4,591,859,517.46, compared to CNY 4,518,083,187.45 at the end of 2019[35] - Total liabilities reached CNY 1,789,323,009.37, with current liabilities at CNY 1,115,075,326.87 and non-current liabilities at CNY 674,247,682.50[64] - The total liabilities to equity ratio stands at approximately 0.66, indicating a balanced capital structure[65] Cash Flow - The net cash flow from operating activities was ¥91,209,626.94, an increase of 28.73% compared to the same period last year[7] - Cash generated from operating activities decreased by 13.12% to ¥212,996,495.85, due to increased cash payments for goods and services[16] - The cash inflow from operating activities amounted to CNY 1,366,513,180.76, an increase from CNY 1,205,116,055.13 in the previous period, representing a growth of approximately 13.36%[56] - The cash outflow for purchasing goods and services was CNY 697,391,667.96, compared to CNY 531,501,094.97, reflecting an increase of approximately 31.23%[56] - The net cash flow from financing activities was -CNY 21,206,077.71, an improvement from -CNY 661,373,167.20, indicating a positive change of about 96.80%[57] Investments - Long-term equity investments increased by 297.97% to ¥9,164,870.30, primarily due to additional investments in subsidiaries[15] - Investment income surged by 488.52% to ¥4,506,326.97, mainly from the disposal of equity in a subsidiary[16] - The company reported a significant increase in long-term equity investments, rising to CNY 9.16 million from CNY 2.30 million at the end of 2019[33] Shareholder Information - Net assets attributable to shareholders of the listed company increased by 15.56% to ¥2,848,798,397.64[7] - The total number of ordinary shareholders at the end of the reporting period was 29,159[11] - The company's cash dividend policy was strictly followed, with a total cash dividend distribution of CNY 26.39 million for the year 2019, amounting to CNY 0.60 per 10 shares[23] Regulatory and Compliance - The company received government subsidies amounting to ¥32,333,922.47 during the reporting period[8] - The company’s board approved the termination of a previous private placement plan due to regulatory changes[17] - The company received approval from the China Securities Regulatory Commission for the registration of a stock issuance to specific investors on October 12, 2020[21] - The company implemented the new revenue recognition standard starting January 1, 2020, affecting the classification of contract liabilities[70] Research and Development - Research and development expenses for the quarter were CNY 30,786,921.36, up from CNY 28,861,888.10 in the previous period[41] - The company's R&D expenses for Q3 2020 were ¥8.25 million, up from ¥7.28 million in Q3 2019, indicating a focus on innovation[45] - Research and development expenses increased to CNY 21.55 million, up 26.3% from CNY 17.05 million in the previous year[51]